Researchers Suggest Lowering Guildelines for Pre-emptive Surgery Against Ovarian Cancer

Researchers Suggest Lowering Guildelines for Pre-emptive Surgery Against Ovarian Cancer
UK researchers have recently suggested that the current guidelines for women to receive risk-reducing salpingo-oophorectomy (RRSO) should be re-evaluated in order to allow the cost-effective and lifesaving procedure for women with as little as 4 percent lifetime risk of developing ovarian cancer (OC). The study, “Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis,” was published in the latest online edition of the Journal of Medical Genetics. About Risk-Reducing Salpingo-Oophorectomy RRSO is the surgical removal of the ovaries and fallopian tubes to prevent ovarian cancer for women typically at high risk due to hereditary, possessing the BRCA1 or BRCA2 gene mutations, or other reasons. Clinically, this procedure is the most effective intervention against ovarian cancer and is currently only recommended for premenopausal women with a greater than 10% lifetime risk of developing ovarian cancer. About this Study To assess the cost-effectiveness of RRSO as a pre-emptive strike against ovarian cancer, the research team analyzed 
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *